CN102153651B — 抗葡聚糖单链抗体及其制备方法
Assigned to Xiamen University · Expires 2012-11-14 · 14y expired
What this patent protects
抗葡聚糖单链抗体及其制备方法。涉及抗葡聚糖的抗体,提供抗葡聚糖单链抗体及其制备方法。克隆抗葡聚糖单链抗体基因,并将其导入载体,构建重组载体;将重组载体导入宿主细菌,构建表达抗葡聚糖单链抗体的重组工程菌;重组工程菌发酵培养,分离纯化发酵液,即得抗葡聚糖单链抗体。利用抗葡聚糖单克隆抗体杂交瘤细胞株D9,通过RT-PCR技术,获得了该抗体的重、轻链可变区序列,进一步组装成抗葡聚糖单链抗体基因,并构建重组表达载体pET-22(b+)-scFv,进行抗葡聚糖单链抗体的表达、纯化与鉴定。在基因工程技术的大背景下,抗葡聚糖单链抗体的获得将有助于未来该抗体的进一…
USPTO Abstract
抗葡聚糖单链抗体及其制备方法。涉及抗葡聚糖的抗体,提供抗葡聚糖单链抗体及其制备方法。克隆抗葡聚糖单链抗体基因,并将其导入载体,构建重组载体;将重组载体导入宿主细菌,构建表达抗葡聚糖单链抗体的重组工程菌;重组工程菌发酵培养,分离纯化发酵液,即得抗葡聚糖单链抗体。利用抗葡聚糖单克隆抗体杂交瘤细胞株D9,通过RT-PCR技术,获得了该抗体的重、轻链可变区序列,进一步组装成抗葡聚糖单链抗体基因,并构建重组表达载体pET-22(b+)-scFv,进行抗葡聚糖单链抗体的表达、纯化与鉴定。在基因工程技术的大背景下,抗葡聚糖单链抗体的获得将有助于未来该抗体的进一步开发和应用。
Drugs covered by this patent
- Injectafer (FERRIC CARBOXYMALTOSE) · Am Regent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.